Esther Dillard: Access to Gene Therapy for Sickle Cell Disease
Esther Dillard, Anchor and Reporter for the Black Information Network at iHeartMedia, shared a post on LinkedIn:
“Gene therapy for sickle cell disease is one of the safest cures medicine has ever produced. A one-time treatment. Not a lifetime of transfusions and pain crises. A cure.
But access isn’t equal.
In this week’s episode of The Color Between the Lines, Dr. Haydar Frangoul explains why families in places like Alabama often have to travel hundreds of miles and wait months just to reach a center that can perform this treatment. That’s not an accident. That’s a choice, about where hospitals invest, who gets access to specialists, and which communities get left out of medical breakthroughs.
Full conversation this week.”
Stay updated with Hemostasis Today.
-
Aug 27, 2026, 16:51Michelle M: The Power of Community in Bleeding Disorders
-
Aug 27, 2026, 16:37Chris Baugh: Stabilize Measure Decide Managing Residual FXa Inhibitor Effects in Urgent Care
-
Aug 27, 2026, 16:26Aurelio Maggio: New Perspectives in The Treatment of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 27, 2026, 16:24Bruno Pougault : Refrigerated Platelets Could Transform Hemorrhage Management
-
Aug 27, 2026, 16:20Women’s Equality and the Fight for Equitable Healthcare – Hemophilia Federation of America
-
Aug 27, 2026, 16:16Thomas Georgas: HIT Requires More Than a Platelet Count
-
Aug 27, 2026, 15:59Leslie Iverson: What Does a Zero CAC Score Really Mean?
-
Aug 27, 2026, 15:42Shahram Raza Shouq: Small Steps Toward a Thalassaemia-Free Future
-
Aug 27, 2026, 15:27Dai H. Chung: A New Foundation for Studying Pediatric Pulmonary Embolism